BML Inc.
Financial Results
Presentation for Fiscal 2020
May 13, 2021
Kensuke Kondo,
President and
Representative Director
Overview of Fiscal 2020
Financial Results
2
10-Year Earnings History
Novel coronavirus PCR tests contributing to increases in both
sales and income
(Millions of yen)
FY2020
3
Year-on-Year Comparison
(Millions of yen) | ||||
FY2019 | FY2020 | Year on | Change | |
year | ||||
Net sales | 120,732 | 138,571 | 17,839 | 14.8% |
Testing business | 115,022 | 132,911 | 17,888 | 15.6% |
Clinical testing business | 110,113 | 128,612 | 18,498 | 16.8% |
Other testing business | 4,908 | 4,299 | (609) | (12.4)% |
Medical informatics business | 4,202 | 4,214 | 12 | 0.3% |
Other businesses | 1,507 | 1,445 | (61) | (4.1)% |
Operating income | 9,763 | 19,936 | 10,172 | 104.2% |
Ordinary income | 10,211 | 20,803 | 10,592 | 103.7% |
Profit attributable to owners of | 6,375 | 13,711 | 7,336 | 115.1% |
parent | ||||
4
Breakdown of Changes in Sales by Business Segment
Net sales up ¥17,839m (14.8%) YoY
(Millions of yen)
609 | 49 | |
138,571 | ||
18,498 | Food hygiene | Medical |
business, etc. | informatics | |
+17,839 | business, | |
Clinical testing | other businesses | |
business |
120,732
5
This is an excerpt of the original content. To continue reading it, access the original document here.